(+)-catechin multiple interactions ISO RGD:619565 6480464 Catechin binds to and results in decreased activity of MAPK14 protein more ... CTD PMID:30453148 (-)-anisomycin multiple interactions ISO RGD:619564 6480464 Anisomycin results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:16364386 (-)-anisomycin increases phosphorylation ISO RGD:619565 6480464 Anisomycin results in increased phosphorylation of MAPK14 protein CTD PMID:10704466 , PMID:16038797 (-)-anisomycin multiple interactions ISO RGD:619565 6480464 MAPK14 protein affects the reaction [Anisomycin results in increased activity of MAPKAPK2 protein] CTD PMID:10704466 (-)-anisomycin multiple interactions EXP 6480464 Anisomycin results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:15961565 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:619564 6480464 [epigallocatechin gallate co-treated with Celecoxib] results in increased activity of MAPK14 protein, [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAPK14 mRNA CTD PMID:16463383 , PMID:22079256 (-)-epigallocatechin 3-gallate increases expression ISO RGD:619564 6480464 epigallocatechin gallate results in increased expression of MAPK14 mRNA CTD PMID:35701726 (1->4)-beta-D-glucan multiple interactions ISO RGD:619565 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MAPK14 mRNA CTD PMID:36331819 (R)-lipoic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of MAPK14 mRNA CTD PMID:23830814 (R,R,R)-alpha-tocopherol multiple interactions ISO RGD:619564 6480464 alpha-Tocopherol inhibits the reaction [[4-hydroxy-2-nonenal co-treated with Hydrogen Peroxide] results in increased activity of MAPK14 protein] more ... CTD PMID:12684028 , PMID:14645110 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO RGD:619564 6480464 MAPK14 protein promotes the reaction [o, p'-DDT results in increased activity of NOTCH1 protein] CTD PMID:18791200 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of MAPK14 mRNA CTD PMID:32387197 1,2-dimethylhydrazine decreases expression ISO RGD:619565 6480464 1, 2-Dimethylhydrazine results in decreased expression of MAPK14 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases phosphorylation ISO RGD:619564 6480464 Dinitrochlorobenzene results in increased phosphorylation of MAPK14 protein CTD PMID:15737199 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:619564 6480464 Dinitrochlorobenzene binds to MAPK14 protein CTD PMID:32991956 1-fluoro-2,4-dinitrobenzene increases phosphorylation ISO RGD:619564 6480464 Dinitrofluorobenzene results in increased phosphorylation of MAPK14 protein CTD PMID:19427879 17alpha-ethynylestradiol increases expression ISO RGD:619565 6480464 Ethinyl Estradiol results in increased expression of MAPK14 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of MAPK14 mRNA CTD PMID:16079270 17beta-estradiol increases activity ISO RGD:619564 6480464 Estradiol results in increased activity of MAPK14 protein CTD PMID:15955695 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:619565 6480464 Dihydrotestosterone results in increased expression of MAPK14 mRNA CTD PMID:17023530 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:619565 6480464 Tetrachlorodibenzodioxin affects the expression of MAPK14 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAPK14 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:619565 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAPK14 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases phosphorylation EXP 6480464 Tetrachlorodibenzodioxin results in increased phosphorylation of MAPK14 protein CTD PMID:23298284 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:619564 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAPK14 mRNA CTD PMID:20702593 2,4,4',6-tetrachlorobiphenyl multiple interactions EXP 6480464 MAPK14 protein promotes the reaction [2 more ... CTD PMID:16120751 2,4-dinitroiodobenzene increases phosphorylation ISO RGD:619564 6480464 1-iodo-2, 4-dinitrobenzene results in increased phosphorylation of MAPK14 protein CTD PMID:19427879 2,6-di-tert-butyl-4-methylphenol increases expression ISO RGD:619565 6480464 Butylated Hydroxytoluene results in increased expression of MAPK14 mRNA CTD PMID:19925653 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:619564 6480464 Glucosamine inhibits the reaction [IL1B results in increased phosphorylation of MAPK14 protein] CTD PMID:19626664 2-butoxyethanol decreases expression ISO RGD:619565 6480464 n-butoxyethanol results in decreased expression of MAPK14 mRNA CTD PMID:19812364 2-hydroxypropanoic acid decreases expression ISO RGD:619564 6480464 Lactic Acid results in decreased expression of MAPK14 mRNA CTD PMID:30851411 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:619565 6480464 3 more ... CTD PMID:19467301 3,4-methylenedioxymethamphetamine increases expression ISO RGD:619565 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of MAPK14 mRNA CTD PMID:20188158 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:619564 6480464 bisindolylmaleimide I inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK14 protein] CTD PMID:16407847 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions EXP 6480464 bisindolylmaleimide I inhibits the reaction [cadmium acetate results in increased phosphorylation of MAPK14 protein] CTD PMID:15925026 3-phenylprop-2-enal decreases phosphorylation EXP 6480464 cinnamaldehyde results in decreased phosphorylation of MAPK14 protein CTD PMID:17486422 3-phenylprop-2-enal multiple interactions ISO RGD:619564 6480464 cinnamaldehyde results in increased phosphorylation of and results in increased activity of MAPK14 protein more ... CTD PMID:15964311 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of MAPK14 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases methylation ISO RGD:619565 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of MAPK14 promoter CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO RGD:619564 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MAPK14 protein CTD PMID:34186270 4-hydroxycyclophosphamide multiple interactions EXP 6480464 [afimoxifene co-treated with 4-hydroxycyclophosphamide] affects the expression of MAPK14 mRNA CTD PMID:25833159 4-hydroxynon-2-enal increases expression ISO RGD:619565 6480464 4-hydroxy-2-nonenal results in increased expression of MAPK14 mRNA CTD PMID:19191707 4-hydroxynon-2-enal multiple interactions ISO RGD:619565 6480464 4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK14 protein, resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:16322078 4-hydroxynon-2-enal multiple interactions ISO RGD:619564 6480464 4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK14 protein more ... CTD PMID:12684028 4-hydroxyphenyl retinamide increases activity ISO RGD:619564 6480464 Fenretinide results in increased activity of MAPK14 protein CTD PMID:16407847 4-hydroxyphenyl retinamide increases phosphorylation ISO RGD:619564 6480464 Fenretinide results in increased phosphorylation of MAPK14 protein CTD PMID:16407847 4-hydroxyphenyl retinamide multiple interactions ISO RGD:619564 6480464 Ascorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK14 protein], bisindolylmaleimide I inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK14 protein] CTD PMID:16407847 4-nitrophenol increases expression ISO RGD:619565 6480464 4-nitrophenol results in increased expression of MAPK14 mRNA CTD PMID:34673133 4-vinylcyclohexene dioxide affects expression ISO RGD:619565 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of MAPK14 mRNA CTD PMID:20829426 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions ISO RGD:619564 6480464 Omeprazole inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK14 protein] CTD PMID:17406807 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MAPK14 mRNA CTD PMID:29896988 abamectin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [abamectin results in increased expression of MAPK14 mRNA] CTD PMID:34748272 abamectin increases expression EXP 6480464 abamectin results in increased expression of MAPK14 mRNA CTD PMID:34748272 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of MAPK14 mRNA CTD PMID:31881176 acetic acid multiple interactions EXP 6480464 Mesalamine inhibits the reaction [Acetic Acid results in increased expression of MAPK14 mRNA], Plant Extracts inhibits the reaction [Acetic Acid results in increased expression of MAPK14 mRNA] CTD PMID:29518435 acetic acid increases expression EXP 6480464 Acetic Acid results in increased expression of MAPK14 mRNA CTD PMID:29518435 acetylsalicylic acid multiple interactions ISO RGD:619564 6480464 Aspirin promotes the reaction [IL1A results in increased phosphorylation of MAPK14 protein], IL1A promotes the reaction [Aspirin results in increased phosphorylation of MAPK14 protein] CTD PMID:14742690 acetylsalicylic acid increases phosphorylation ISO RGD:619564 6480464 Aspirin results in increased phosphorylation of MAPK14 protein CTD PMID:14742690 acrolein increases phosphorylation EXP 6480464 [Acrolein results in increased phosphorylation of MAPK14 protein] which results in increased phosphorylation of ATF2 protein, Acrolein results in increased phosphorylation of MAPK14 protein CTD PMID:12487375 acrolein increases phosphorylation ISO RGD:619564 6480464 Acrolein results in increased phosphorylation of MAPK14 protein CTD PMID:11329622 more ... acrolein multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Acrolein results in increased phosphorylation of MAPK14 protein] CTD PMID:12487375 acrolein multiple interactions ISO RGD:619564 6480464 RTKI cpd inhibits the reaction [Acrolein results in increased phosphorylation of MAPK14 protein] CTD PMID:11329622 afimoxifene multiple interactions EXP 6480464 [afimoxifene co-treated with 4-hydroxycyclophosphamide] affects the expression of MAPK14 mRNA CTD PMID:25833159 afimoxifene decreases response to substance ISO RGD:619564 6480464 MAPK14 results in decreased susceptibility to afimoxifene CTD PMID:21233418 aflatoxin B1 affects methylation ISO RGD:619564 6480464 Aflatoxin B1 affects the methylation of MAPK14 intron CTD PMID:30157460 aldehydo-D-glucosamine multiple interactions ISO RGD:619564 6480464 Glucosamine inhibits the reaction [IL1B results in increased phosphorylation of MAPK14 protein] CTD PMID:19626664 aldehydo-D-glucose multiple interactions ISO RGD:619565 6480464 [resveratrol co-treated with Glucose] results in decreased expression of MAPK14 mRNA, Glucose promotes the reaction [EIF2AK2 protein results in increased activity of MAPK14 protein] CTD PMID:18973755 , PMID:24659233 aldehydo-D-glucose decreases phosphorylation ISO RGD:619564 6480464 Glucose results in decreased phosphorylation of MAPK14 protein CTD PMID:20200188 aldehydo-D-glucose increases activity ISO RGD:619564 6480464 Glucose deficiency results in increased activity of MAPK14 protein CTD PMID:17309078 aldehydo-D-glucose multiple interactions ISO RGD:619564 6480464 CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK14 protein] more ... CTD PMID:17309078 , PMID:21829520 aldosterone affects chemical synthesis ISO RGD:619564 6480464 MAPK14 protein affects the chemical synthesis of Aldosterone CTD PMID:14592955 alendronic acid affects expression EXP 6480464 Alendronate affects the expression of MAPK14 mRNA CTD PMID:16079270 all-trans-retinoic acid multiple interactions ISO RGD:619564 6480464 [Tretinoin results in increased activity of MAPK14 protein] which results in increased phosphorylation of and results in increased degradation of NCOA3 protein CTD PMID:16456540 all-trans-retinoic acid increases expression ISO RGD:619564 6480464 Tretinoin results in increased expression of MAPK14 mRNA CTD PMID:23724009 , PMID:33167477 all-trans-retinoic acid decreases expression ISO RGD:619564 6480464 Tretinoin results in decreased expression of MAPK14 mRNA CTD PMID:15498508 all-trans-retinoic acid decreases activity ISO RGD:619565 6480464 Tretinoin results in decreased activity of MAPK14 protein CTD PMID:16424397 all-trans-retinoic acid multiple interactions ISO RGD:619565 6480464 Imatinib Mesylate inhibits the reaction [Tretinoin results in increased phosphorylation of MAPK14 protein] more ... CTD PMID:12032135 allopurinol multiple interactions ISO RGD:619564 6480464 Allopurinol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein] CTD PMID:15650392 alvocidib multiple interactions ISO RGD:619564 6480464 [alvocidib co-treated with ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate] results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:15634644 amifostine multiple interactions ISO RGD:619565 6480464 Amifostine inhibits the reaction [Lipopolysaccharides results in increased activity of and results in increased phosphorylation of MAPK14 protein] CTD PMID:19010997 amiodarone increases phosphorylation EXP 6480464 Amiodarone results in increased phosphorylation of MAPK14 protein CTD PMID:34590760 amiodarone multiple interactions EXP 6480464 [Losartan co-treated with Vitamin D] inhibits the reaction [Amiodarone results in increased phosphorylation of MAPK14 protein] more ... CTD PMID:34590760 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAPK14 mRNA CTD PMID:16483693 aniline increases phosphorylation EXP 6480464 aniline results in increased phosphorylation of MAPK14 protein CTD PMID:16169568 , PMID:18420242 anthra[1,9-cd]pyrazol-6(2H)-one decreases phosphorylation EXP 6480464 pyrazolanthrone results in decreased phosphorylation of MAPK14 protein CTD PMID:16046226 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:619564 6480464 pyrazolanthrone inhibits the reaction [cinnamaldehyde results in increased phosphorylation of MAPK14 protein] CTD PMID:15964311 anthra[1,9-cd]pyrazol-6(2H)-one increases expression EXP 6480464 pyrazolanthrone results in increased expression of MAPK14 protein CTD PMID:16046226 antimycin A multiple interactions ISO RGD:619564 6480464 Antimycin A inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein] CTD PMID:15650392 arachidonic acid multiple interactions ISO RGD:619564 6480464 MAPK14 mutant form inhibits the reaction [Arachidonic Acid affects the localization of BAX protein] more ... CTD PMID:19540902 arachidonic acid multiple interactions EXP 6480464 MAPK14 protein promotes the reaction [2 more ... CTD PMID:16120751 arsane affects methylation ISO RGD:619564 6480464 Arsenic affects the methylation of MAPK14 gene CTD PMID:25304211 arsane increases expression ISO RGD:619564 6480464 Arsenic results in increased expression of MAPK14 mRNA CTD PMID:33736254 arsane multiple interactions ISO RGD:619564 6480464 [Palmitic Acid co-treated with Arsenic] results in increased expression of MAPK14 mRNA CTD PMID:33736254 arsenic atom affects methylation ISO RGD:619564 6480464 Arsenic affects the methylation of MAPK14 gene CTD PMID:25304211 arsenic atom multiple interactions ISO RGD:619564 6480464 [Palmitic Acid co-treated with Arsenic] results in increased expression of MAPK14 mRNA CTD PMID:33736254 arsenic atom increases expression ISO RGD:619564 6480464 Arsenic results in increased expression of MAPK14 mRNA CTD PMID:33736254 arsenite(3-) increases phosphorylation EXP 6480464 arsenite results in increased phosphorylation of MAPK14 protein CTD PMID:17038550 arsenite(3-) increases phosphorylation ISO RGD:619564 6480464 arsenite results in increased phosphorylation of MAPK14 protein CTD PMID:36534342 arsenite(3-) multiple interactions ISO RGD:619564 6480464 MAPK14 mutant form inhibits the reaction [arsenite results in increased ubiquitination of and results in increased degradation of CCNB1 protein] more ... CTD PMID:12781867 more ... arsenous acid multiple interactions ISO RGD:619564 6480464 3 more ... CTD PMID:12239215 more ... arsenous acid increases phosphorylation ISO RGD:619564 6480464 Arsenic Trioxide results in increased phosphorylation of MAPK14 protein CTD PMID:36509116 arsenous acid multiple interactions ISO RGD:619565 6480464 Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein more ... CTD PMID:16818652 arsenous acid decreases response to substance ISO RGD:619564 6480464 MAPK14 results in decreased susceptibility to Arsenic Trioxide CTD PMID:16818652 asbestos increases activity ISO RGD:619564 6480464 Asbestos results in increased activity of MAPK14 protein CTD PMID:10660835 Asiaticoside multiple interactions EXP 6480464 asiaticoside inhibits the reaction [Rotenone results in decreased expression of MAPK14 protein] CTD PMID:28238857 atorvastatin calcium multiple interactions ISO RGD:619565 6480464 Atorvastatin inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein] CTD PMID:20305681 atorvastatin calcium multiple interactions EXP 6480464 Atorvastatin inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK14 protein] CTD PMID:17589825 atorvastatin calcium multiple interactions ISO RGD:619564 6480464 Atorvastatin inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein] CTD PMID:19767766 , PMID:20018284 atropine multiple interactions EXP 6480464 [asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman results in increased phosphorylation of MAPK14 protein] CTD PMID:21971501 aucubin increases phosphorylation ISO RGD:619564 6480464 aucubin results in increased phosphorylation of MAPK14 protein CTD PMID:29408431 benzalkonium chloride increases phosphorylation ISO RGD:619564 6480464 Benzalkonium Compounds results in increased phosphorylation of MAPK14 protein CTD PMID:15737199 benzene increases expression ISO RGD:619564 6480464 Benzene results in increased expression of MAPK14 mRNA CTD PMID:33064461 benzo[a]pyrene multiple interactions ISO RGD:619565 6480464 MAPK14 protein promotes the reaction [TNF protein promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]] CTD PMID:25233930 benzo[a]pyrene increases expression ISO RGD:619564 6480464 Benzo(a)pyrene metabolite results in increased expression of MAPK14 mRNA CTD PMID:26314263 benzo[a]pyrene affects expression ISO RGD:619564 6480464 Benzo(a)pyrene affects the expression of MAPK14 mRNA CTD PMID:20702593 benzo[a]pyrene increases phosphorylation ISO RGD:619564 6480464 Benzo(a)pyrene results in increased phosphorylation of MAPK14 protein CTD PMID:15698582 Benzo[a]pyrene-7,8-diol increases phosphorylation ISO RGD:619564 6480464 benzo(a)pyrene 7, 8-dihydrodiol results in increased phosphorylation of MAPK14 protein CTD PMID:15698582 Benzo[k]fluoranthene increases phosphorylation ISO RGD:619564 6480464 benzo(k)fluoranthene results in increased phosphorylation of MAPK14 protein CTD PMID:21635667 Benzo[k]fluoranthene multiple interactions ISO RGD:619564 6480464 Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased phosphorylation of MAPK14 protein], SB 203580 inhibits the reaction [benzo(k)fluoranthene results in increased phosphorylation of MAPK14 protein] CTD PMID:21635667 beta-D-glucosamine multiple interactions ISO RGD:619564 6480464 Glucosamine inhibits the reaction [IL1B results in increased phosphorylation of MAPK14 protein] CTD PMID:19626664 bis(2-chloroethyl) sulfide increases expression ISO RGD:619565 6480464 Mustard Gas results in increased expression of MAPK14 mRNA CTD PMID:15674844 bis(2-chloroethyl) sulfide affects response to substance ISO RGD:619564 6480464 MAPK14 protein affects the susceptibility to Mustard Gas CTD PMID:23851002 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:619564 6480464 MAPK14 mutant form inhibits the reaction [Mustard Gas results in increased expression of CXCL8 protein] more ... CTD PMID:20143454 , PMID:23851002 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAPK14 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A decreases expression ISO RGD:619564 6480464 bisphenol A results in decreased expression of MAPK14 protein CTD PMID:34186270 bisphenol A multiple interactions ISO RGD:619564 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of MAPK14 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:619565 6480464 bisphenol A results in increased expression of MAPK14 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAPK14 mRNA CTD PMID:33296240 bortezomib multiple interactions ISO RGD:619564 6480464 [Bortezomib co-treated with Butyrates] results in increased phosphorylation of MAPK14 protein more ... CTD PMID:12893773 , PMID:18790767 bromobenzene increases phosphorylation ISO RGD:619564 6480464 bromobenzene analog results in increased phosphorylation of MAPK14 protein CTD PMID:19427879 bupropion multiple interactions ISO RGD:619564 6480464 Bupropion results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:21354251 butylated hydroxyanisole multiple interactions ISO RGD:619565 6480464 Butylated Hydroxyanisole inhibits the reaction [MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased activity of MAPK8 protein]] more ... CTD PMID:18691550 cadmium atom multiple interactions ISO RGD:619564 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAPK14 mRNA, SB 203580 inhibits the reaction [Cadmium results in increased phosphorylation of MAPK14 protein] CTD PMID:20232314 , PMID:35301059 cadmium atom increases phosphorylation ISO RGD:619564 6480464 Cadmium results in increased phosphorylation of MAPK14 protein CTD PMID:20232314 cadmium dichloride multiple interactions ISO RGD:619564 6480464 1 more ... CTD PMID:18703135 more ... cadmium dichloride increases expression ISO RGD:619564 6480464 Cadmium Chloride results in increased expression of MAPK14 mRNA CTD PMID:32512071 , PMID:33129824 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of MAPK14 mRNA CTD PMID:33453195 cadmium dichloride increases phosphorylation ISO RGD:619564 6480464 Cadmium Chloride results in increased phosphorylation of MAPK14 protein CTD PMID:16264267 more ... cadmium dichloride increases phosphorylation EXP 6480464 Cadmium Chloride results in increased phosphorylation of MAPK14 protein CTD PMID:18703135 , PMID:21933187 cadmium dichloride multiple interactions EXP 6480464 1 more ... CTD PMID:18703135 more ... cadmium dichloride increases phosphorylation ISO RGD:619565 6480464 Cadmium Chloride results in increased phosphorylation of MAPK14 protein CTD PMID:18348256 cadmium dichloride multiple interactions ISO RGD:619565 6480464 1 more ... CTD PMID:10874044 more ... cadmium dichloride decreases expression ISO RGD:619564 6480464 Cadmium Chloride results in decreased expression of MAPK14 mRNA CTD PMID:19757093 cadmium selenide multiple interactions ISO RGD:619564 6480464 [cadmium selenide co-treated with zinc sulfide] results in increased expression of MAPK14 mRNA more ... CTD PMID:22342292 calcitriol increases activity ISO RGD:619564 6480464 Calcitriol results in increased activity of MAPK14 protein CTD PMID:19748465 calcitriol multiple interactions EXP 6480464 [Calcitriol co-treated with TGFB1 protein] results in increased phosphorylation of MAPK14 protein CTD PMID:16598785 calcitriol increases phosphorylation EXP 6480464 Calcitriol results in increased phosphorylation of MAPK14 protein CTD PMID:16598785 calcitriol multiple interactions ISO RGD:619564 6480464 [CAMP results in increased activity of MAPK14] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA] more ... CTD PMID:19748465 calcium atom affects expression EXP 6480464 Calcium affects the expression of MAPK14 mRNA CTD PMID:15913539 calcium(0) affects expression EXP 6480464 Calcium affects the expression of MAPK14 mRNA CTD PMID:15913539 cannabidiol decreases expression EXP 6480464 Cannabidiol results in decreased expression of MAPK14 mRNA CTD PMID:32553926 cannabidiol decreases expression ISO RGD:619564 6480464 Cannabidiol results in decreased expression of MAPK14 mRNA CTD PMID:27714895 more ... capsaicin multiple interactions ISO RGD:619564 6480464 Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK14 protein] CTD PMID:21745629 carbamazepine affects expression ISO RGD:619564 6480464 Carbamazepine affects the expression of MAPK14 mRNA CTD PMID:24752500 carbon monoxide multiple interactions ISO RGD:619564 6480464 MAPK14 protein affects the reaction [BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]], MAPK14 protein affects the reaction [BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]] CTD PMID:11880364 carbon nanotube increases phosphorylation ISO RGD:619564 6480464 Nanotubes, Carbon analog results in increased phosphorylation of MAPK14 protein CTD PMID:20800606 carboplatin decreases expression EXP 6480464 Carboplatin results in decreased expression of MAPK14 mRNA CTD PMID:18172885 carvedilol multiple interactions EXP 6480464 carvedilol inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK14 protein] CTD PMID:16213474 celecoxib multiple interactions ISO RGD:619564 6480464 [epigallocatechin gallate co-treated with Celecoxib] results in increased activity of MAPK14 protein CTD PMID:16463383 CGP 52608 multiple interactions ISO RGD:619564 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAPK14 gene] CTD PMID:28238834 chalcone multiple interactions ISO RGD:619565 6480464 Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] CTD PMID:22155221 chlorogenic acid multiple interactions ISO RGD:619565 6480464 Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK14 protein] CTD PMID:15944151 chloroquine multiple interactions ISO RGD:619564 6480464 Chloroquine inhibits the reaction [hydroquinone results in increased phosphorylation of MAPK14 protein] CTD PMID:35302183 chlorpromazine decreases expression ISO RGD:619564 6480464 Chlorpromazine analog results in decreased expression of MAPK14 mRNA CTD PMID:15924885 chlorpyrifos multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Chlorpyrifos results in increased expression of MAPK14 protein] CTD PMID:33908150 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of MAPK14 protein CTD PMID:33908150 cholesterol multiple interactions EXP 6480464 [Cholesterol co-treated with Ergosterol] results in increased expression of MAPK14 mRNA, resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of MAPK14 mRNA] CTD PMID:25833014 chromium(6+) increases phosphorylation ISO RGD:619564 6480464 chromium hexavalent ion results in increased phosphorylation of MAPK14 protein CTD PMID:17045426 chrysophanol affects phosphorylation ISO RGD:619564 6480464 chrysophanic acid affects the phosphorylation of MAPK14 protein CTD PMID:30300626 ciglitazone multiple interactions ISO RGD:619564 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of MAPK14 mRNA CTD PMID:16197558 cisplatin increases phosphorylation ISO RGD:619565 6480464 Cisplatin results in increased phosphorylation of MAPK14 protein CTD PMID:22006019 , PMID:35304134 cisplatin multiple interactions ISO RGD:619565 6480464 Rutin inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK14 protein] CTD PMID:35304134 clotrimazole multiple interactions ISO RGD:619564 6480464 MAPK14 promotes the reaction [Clotrimazole results in increased expression of ABCC3 mRNA] CTD PMID:27507784 clozapine affects expression EXP 6480464 Clozapine affects the expression of MAPK14 mRNA CTD PMID:15860345 cobalt dichloride multiple interactions EXP 6480464 MAPK14 mutant form inhibits the reaction [cobaltous chloride results in increased expression of NOS2 protein], MAPK14 mutant form inhibits the reaction [cobaltous chloride results in increased secretion of IL6 protein] CTD PMID:23624824 cobalt dichloride increases expression ISO RGD:619564 6480464 cobaltous chloride results in increased expression of MAPK14 mRNA CTD PMID:26314263 cocaine increases activity ISO RGD:619565 6480464 Cocaine results in increased activity of MAPK14 protein CTD PMID:18952886 coniferyl aldehyde multiple interactions ISO RGD:619564 6480464 MAPK14 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein], MAPK14 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein] CTD PMID:26275128 copper(II) sulfate affects expression ISO RGD:619564 6480464 Copper Sulfate affects the expression of MAPK14 mRNA CTD PMID:19549813 copper(II) sulfate increases expression ISO RGD:619565 6480464 Copper Sulfate results in increased expression of MAPK14 mRNA CTD PMID:33744278 crocidolite asbestos multiple interactions ISO RGD:619564 6480464 Asbestos more ... CTD PMID:14962975 more ... crocidolite asbestos decreases expression ISO RGD:619565 6480464 Asbestos, Crocidolite results in decreased expression of MAPK14 mRNA CTD PMID:29279043 crocidolite asbestos increases phosphorylation ISO RGD:619564 6480464 Asbestos, Crocidolite results in increased phosphorylation of MAPK14 protein CTD PMID:18314537 curcumin multiple interactions ISO RGD:619564 6480464 Curcumin inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased phosphorylation of MAPK14 protein] more ... CTD PMID:17151092 more ... cycloheximide multiple interactions ISO RGD:619564 6480464 Cycloheximide inhibits the reaction [Asbestos, Crocidolite results in decreased phosphorylation of MAPK14 protein] CTD PMID:17507666 cyclophosphamide multiple interactions ISO RGD:619564 6480464 [Doxorubicin co-treated with Cyclophosphamide] affects the expression of MAPK14 mRNA CTD PMID:16322899 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of MAPK14 mRNA CTD PMID:18246545 cyclophosphamide affects expression EXP 6480464 Cyclophosphamide affects the expression of MAPK14 mRNA CTD PMID:18246545 D-glucitol increases phosphorylation ISO RGD:619564 6480464 Sorbitol results in increased phosphorylation of MAPK14 protein CTD PMID:15362974 D-glucose multiple interactions ISO RGD:619564 6480464 CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK14 protein] more ... CTD PMID:17309078 , PMID:21829520 D-glucose multiple interactions ISO RGD:619565 6480464 [Resveratrol co-treated with Glucose] results in decreased expression of MAPK14 mRNA, Glucose promotes the reaction [EIF2AK2 protein results in increased activity of MAPK14 protein] CTD PMID:18973755 , PMID:24659233 D-glucose decreases phosphorylation ISO RGD:619564 6480464 Glucose results in decreased phosphorylation of MAPK14 protein CTD PMID:20200188 D-glucose increases activity ISO RGD:619564 6480464 Glucose deficiency results in increased activity of MAPK14 protein CTD PMID:17309078 DDT increases phosphorylation ISO RGD:619564 6480464 DDT results in increased phosphorylation of MAPK14 protein CTD PMID:14604893 deoxynivalenol multiple interactions ISO RGD:619564 6480464 deoxynivalenol results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:16364386 deoxynivalenol increases expression ISO RGD:619564 6480464 deoxynivalenol results in increased expression of MAPK14 mRNA CTD PMID:20702593 deoxynivalenol increases phosphorylation ISO RGD:619565 6480464 deoxynivalenol results in increased phosphorylation of MAPK14 protein CTD PMID:15976193 desipramine increases activity ISO RGD:619564 6480464 Desipramine results in increased activity of MAPK14 protein CTD PMID:18986328 dexamethasone multiple interactions ISO RGD:619564 6480464 Dexamethasone inhibits the reaction [Mitomycin results in increased activity of and results in increased phosphorylation of MAPK14 protein] more ... CTD PMID:15817653 , PMID:20002897 dexamethasone increases expression ISO RGD:619565 6480464 Dexamethasone results in increased expression of MAPK14 mRNA CTD PMID:22733784 dexamethasone multiple interactions EXP 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Dexamethasone affects the localization of MAPK14 protein modified form] more ... CTD PMID:20181797 , PMID:21094144 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of MAPK14 protein CTD PMID:21094144 dexamethasone multiple interactions ISO RGD:619565 6480464 [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein] more ... CTD PMID:14984747 , PMID:16880258 dexamethasone increases activity ISO RGD:619564 6480464 Dexamethasone results in increased activity of MAPK14 protein CTD PMID:11012613 diarsenic trioxide multiple interactions ISO RGD:619564 6480464 3 more ... CTD PMID:12239215 more ... diarsenic trioxide increases phosphorylation ISO RGD:619564 6480464 Arsenic Trioxide results in increased phosphorylation of MAPK14 protein CTD PMID:36509116 diarsenic trioxide multiple interactions ISO RGD:619565 6480464 Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein more ... CTD PMID:16818652 diarsenic trioxide decreases response to substance ISO RGD:619564 6480464 MAPK14 results in decreased susceptibility to Arsenic Trioxide CTD PMID:16818652 diazepam multiple interactions EXP 6480464 [asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman results in increased phosphorylation of MAPK14 protein] CTD PMID:21971501 dibenziodolium multiple interactions ISO RGD:619564 6480464 diphenyleneiodonium inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein] CTD PMID:19767766 dibenzo[a,l]pyrene multiple interactions EXP 6480464 dibenzo(a more ... CTD PMID:16005925 diclofenac affects expression ISO RGD:619564 6480464 Diclofenac affects the expression of MAPK14 mRNA CTD PMID:24752500 Dictamnine multiple interactions ISO RGD:619564 6480464 dictamnine inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK14 protein] CTD PMID:30266538 diminazene diaceturate decreases phosphorylation EXP 6480464 diminazene aceturate results in decreased phosphorylation of MAPK14 protein CTD PMID:25883526 diosmetin multiple interactions ISO RGD:619565 6480464 diosmetin inhibits the reaction [RANK Ligand results in increased phosphorylation of MAPK14 protein] CTD PMID:36563736 dioxygen multiple interactions ISO RGD:619564 6480464 dictamnine inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK14 protein] CTD PMID:30266538 dioxygen increases phosphorylation ISO RGD:619564 6480464 Oxygen deficiency results in increased phosphorylation of MAPK14 protein CTD PMID:30266538 doramapimod decreases activity ISO RGD:619564 6480464 doramapimod results in decreased activity of MAPK14 protein CTD PMID:28629242 doxorubicin affects activity ISO RGD:619564 6480464 Doxorubicin affects the activity of MAPK14 protein CTD PMID:15870702 doxorubicin decreases expression ISO RGD:619564 6480464 Doxorubicin results in decreased expression of MAPK14 mRNA CTD PMID:29803840 doxorubicin increases phosphorylation EXP 6480464 Doxorubicin results in increased phosphorylation of MAPK14 protein CTD PMID:15767673 , PMID:16213474 doxorubicin multiple interactions EXP 6480464 [SB 203580 results in decreased activity of MAPK14 protein] which results in decreased susceptibility to Doxorubicin more ... CTD PMID:15936597 , PMID:16213474 doxorubicin increases phosphorylation ISO RGD:619564 6480464 Doxorubicin results in increased phosphorylation of MAPK14 protein CTD PMID:15557793 doxorubicin multiple interactions ISO RGD:619564 6480464 [Doxorubicin co-treated with Cyclophosphamide] affects the expression of MAPK14 mRNA more ... CTD PMID:15494689 more ... doxycycline multiple interactions ISO RGD:619565 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK14 protein] CTD PMID:18089841 ellagic acid multiple interactions EXP 6480464 Ellagic Acid inhibits the reaction [phosalone results in increased expression of MAPK14 protein] CTD PMID:27965107 emetine multiple interactions ISO RGD:619564 6480464 Emetine results in increased phosphorylation of and results in increased activity of MAPK14 protein more ... CTD PMID:16364386 , PMID:26332055 emodin multiple interactions ISO RGD:619564 6480464 Acetylcysteine inhibits the reaction [Emodin promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]], Emodin promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:14729614 endosulfan multiple interactions ISO RGD:619564 6480464 Endosulfan results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:22146149 ergosterol multiple interactions EXP 6480464 [Cholesterol co-treated with Ergosterol] results in increased expression of MAPK14 mRNA, resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of MAPK14 mRNA] CTD PMID:25833014 esculetin multiple interactions ISO RGD:619564 6480464 [esculetin co-treated with Paclitaxel] results in decreased expression of MAPK14 protein, esculetin results in decreased phosphorylation of and results in decreased activity of MAPK14 protein CTD PMID:16051289 etacrynic acid decreases expression ISO RGD:619564 6480464 Ethacrynic Acid results in decreased expression of MAPK14 protein CTD PMID:14556662 ethanol affects expression EXP 6480464 Ethanol affects the expression of MAPK14 mRNA CTD PMID:11772933 ethanol multiple interactions ISO RGD:619565 6480464 MAPK14 protein promotes the reaction [Ethanol results in increased expression of and results in increased phosphorylation of TP53 protein], MAPK14 protein promotes the reaction [Ethanol results in increased expression of CASP3 protein modified form] CTD PMID:27270636 ethanol increases response to substance ISO RGD:619565 6480464 MAPK14 protein results in increased susceptibility to Ethanol CTD PMID:27270636 ethoxyquin multiple interactions ISO RGD:619565 6480464 [Ethoxyquin results in increased expression of PRDX1 protein] which results in increased phosphorylation of MAPK14 protein CTD PMID:16880205 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions ISO RGD:619565 6480464 Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:21544200 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions EXP 6480464 Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:21544200 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions ISO RGD:619564 6480464 Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:21544200 ferric ammonium citrate increases phosphorylation ISO RGD:619564 6480464 ferric ammonium citrate results in increased phosphorylation of MAPK14 protein CTD PMID:17191120 fluoxetine increases phosphorylation ISO RGD:619565 6480464 Fluoxetine results in increased phosphorylation of MAPK14 protein CTD PMID:16413968 flurbiprofen multiple interactions ISO RGD:619564 6480464 MAPK14 protein promotes the reaction [Flurbiprofen results in increased expression of GDF15 protein] more ... CTD PMID:18056468 , PMID:21097678 folic acid multiple interactions EXP 6480464 [Folic Acid co-treated with Genistein] inhibits the reaction [amyloid beta-protein (31-35) results in increased expression of MAPK14 mRNA], Folic Acid inhibits the reaction [amyloid beta-protein (31-35) results in increased expression of MAPK14 mRNA] CTD PMID:21205217 formaldehyde increases phosphorylation ISO RGD:619564 6480464 Formaldehyde results in increased phosphorylation of MAPK14 protein CTD PMID:15737199 , PMID:36534342 formaldehyde multiple interactions ISO RGD:619564 6480464 Formaldehyde affects the reaction [SET protein alternative form binds to MAPK14 protein modified form], SET protein alternative form affects the reaction [Formaldehyde results in increased phosphorylation of MAPK14 protein] CTD PMID:36534342 formaldehyde affects localization ISO RGD:619564 6480464 Formaldehyde affects the localization of MAPK14 protein CTD PMID:36534342 fulvestrant multiple interactions ISO RGD:619564 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of MAPK14 gene CTD PMID:31601247 genistein decreases expression ISO RGD:619565 6480464 Genistein results in decreased expression of MAPK14 mRNA CTD PMID:21048042 genistein multiple interactions EXP 6480464 [Folic Acid co-treated with Genistein] inhibits the reaction [amyloid beta-protein (31-35) results in increased expression of MAPK14 mRNA], Genistein inhibits the reaction [amyloid beta-protein (31-35) results in increased expression of MAPK14 mRNA] CTD PMID:21205217 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MAPK14 mRNA, Gentamicins results in increased expression of MAPK14 protein CTD PMID:16751989 , PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of MAPK14 mRNA CTD PMID:33387578 glucose multiple interactions ISO RGD:619564 6480464 CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK14 protein] more ... CTD PMID:17309078 , PMID:21829520 glucose multiple interactions ISO RGD:619565 6480464 [resveratrol co-treated with Glucose] results in decreased expression of MAPK14 mRNA, Glucose promotes the reaction [EIF2AK2 protein results in increased activity of MAPK14 protein] CTD PMID:18973755 , PMID:24659233 glucose decreases phosphorylation ISO RGD:619564 6480464 Glucose results in decreased phosphorylation of MAPK14 protein CTD PMID:20200188 glucose increases activity ISO RGD:619564 6480464 Glucose deficiency results in increased activity of MAPK14 protein CTD PMID:17309078 haloperidol affects expression EXP 6480464 Haloperidol affects the expression of MAPK14 mRNA CTD PMID:15860345 halothane increases expression ISO RGD:619565 6480464 Halothane results in increased expression of MAPK14 mRNA CTD PMID:24598351 halothane decreases expression ISO RGD:619565 6480464 Halothane results in decreased expression of MAPK14 protein CTD PMID:24598351 hemin multiple interactions ISO RGD:619564 6480464 Hemin inhibits the reaction [IL18 protein results in increased expression of MAPK14 protein] CTD PMID:18215737 hesperidin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [abamectin results in increased expression of MAPK14 mRNA] more ... CTD PMID:33908150 more ... hexachlorobenzene affects expression EXP 6480464 Hexachlorobenzene affects the expression of MAPK14 mRNA CTD PMID:15159207 hexadecanoic acid multiple interactions ISO RGD:619564 6480464 [Palmitic Acid co-treated with Arsenic] results in increased expression of MAPK14 mRNA, Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK14 protein] CTD PMID:21745629 , PMID:33736254 hexadecanoic acid increases phosphorylation ISO RGD:619564 6480464 Palmitic Acid results in increased phosphorylation of MAPK14 protein CTD PMID:21745629 homocysteine multiple interactions ISO RGD:619564 6480464 Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein] more ... CTD PMID:19767766 , PMID:20018284 homocysteine increases phosphorylation ISO RGD:619565 6480464 Homocysteine results in increased phosphorylation of MAPK14 protein CTD PMID:20305681 homocysteine multiple interactions ISO RGD:619565 6480464 Atorvastatin inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein] CTD PMID:20305681 homocysteine increases phosphorylation ISO RGD:619564 6480464 Homocysteine results in increased phosphorylation of MAPK14 protein CTD PMID:19767766 , PMID:20018284 hydrogen peroxide multiple interactions ISO RGD:619564 6480464 Acetylcysteine inhibits the reaction [[4-hydroxy-2-nonenal co-treated with Hydrogen Peroxide] results in increased activity of MAPK14 protein] more ... CTD PMID:12684028 more ... hydrogen peroxide increases expression ISO RGD:619564 6480464 Hydrogen Peroxide results in increased expression of MAPK14 mRNA CTD PMID:31521693 hydrogen peroxide increases activity EXP 6480464 Hydrogen Peroxide results in increased activity of MAPK14 protein CTD PMID:15574683 , PMID:8971075 hydrogen peroxide multiple interactions EXP 6480464 Progesterone promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein], SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK14 protein] CTD PMID:16284289 , PMID:8971075 hydrogen peroxide increases phosphorylation EXP 6480464 Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein CTD PMID:16284289 hydrogen peroxide increases phosphorylation ISO RGD:619565 6480464 Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein CTD PMID:19010997 hydrogen peroxide multiple interactions ISO RGD:619565 6480464 PRDX1 protein promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein] CTD PMID:16880205 hydrogen peroxide increases phosphorylation ISO RGD:619564 6480464 Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein CTD PMID:15650392 hydroquinone increases phosphorylation ISO RGD:619564 6480464 hydroquinone results in increased phosphorylation of MAPK14 protein CTD PMID:35302183 hydroquinone multiple interactions ISO RGD:619564 6480464 Chloroquine inhibits the reaction [hydroquinone results in increased phosphorylation of MAPK14 protein] CTD PMID:35302183 ibuprofen multiple interactions ISO RGD:619564 6480464 MAPK14 protein promotes the reaction [Ibuprofen results in increased expression of GDF15 protein] more ... CTD PMID:18056468 , PMID:21097678 Indeno[1,2,3-cd]pyrene increases phosphorylation ISO RGD:619564 6480464 indeno(1 more ... CTD PMID:21635667 Indeno[1,2,3-cd]pyrene multiple interactions ISO RGD:619564 6480464 Acetylcysteine inhibits the reaction [indeno(1 more ... CTD PMID:21635667 iohexol increases expression ISO RGD:619564 6480464 Iohexol results in increased expression of MAPK14 mRNA CTD PMID:29705293 iopamidol increases expression ISO RGD:619564 6480464 Iopamidol results in increased expression of MAPK14 mRNA CTD PMID:29705293 isoprenaline multiple interactions ISO RGD:619565 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK14 protein] CTD PMID:18089841 isoprenaline increases phosphorylation ISO RGD:619565 6480464 Isoproterenol results in increased phosphorylation of MAPK14 protein CTD PMID:18089841 ivermectin decreases expression ISO RGD:619564 6480464 Ivermectin results in decreased expression of MAPK14 protein CTD PMID:32959892 kaempferol multiple interactions EXP 6480464 [kaempferol inhibits the reaction [Lipopolysaccharides co-treated with HIF1A protein]] which results in increased expression of MAPK14 protein, [kaempferol inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in increased phosphorylation of MAPK14 protein CTD PMID:36049518 KN-93 multiple interactions EXP 6480464 KN 93 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK14 protein] CTD PMID:21933187 L-ascorbic acid multiple interactions ISO RGD:619564 6480464 Ascorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK14 protein] CTD PMID:16407847 L-cysteine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Cysteine deficiency] results in increased activity of MAPK14 protein more ... CTD PMID:11709198 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Cysteine deficiency] results in increased activity of MAPK14 protein more ... CTD PMID:11709198 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of MAPK14 CTD PMID:24293362 limonene increases expression EXP 6480464 limonene results in increased expression of MAPK14 mRNA CTD PMID:12815608 lipoic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of MAPK14 mRNA CTD PMID:23830814 lipopolysaccharide multiple interactions ISO RGD:619564 6480464 ARHGEF2 mutant form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] more ... CTD PMID:17698565 more ... lipopolysaccharide multiple interactions EXP 6480464 [kaempferol inhibits the reaction [Lipopolysaccharides co-treated with HIF1A protein]] which results in increased expression of MAPK14 protein more ... CTD PMID:36049518 lipopolysaccharide increases phosphorylation ISO RGD:619565 6480464 Lipopolysaccharides results in increased phosphorylation of MAPK14 protein CTD PMID:10704466 more ... lipopolysaccharide increases expression ISO RGD:619565 6480464 Lipopolysaccharides results in increased expression of MAPK14 mRNA CTD PMID:25843059 lipopolysaccharide increases phosphorylation ISO RGD:619564 6480464 Lipopolysaccharides results in increased phosphorylation of MAPK14 protein CTD PMID:21911040 more ... lipopolysaccharide decreases activity ISO RGD:619564 6480464 Lipopolysaccharides results in decreased activity of MAPK14 protein CTD PMID:14997032 lipopolysaccharide multiple interactions ISO RGD:619565 6480464 1-dodecylsulfonyl-5N more ... CTD PMID:15778123 more ... losartan decreases expression EXP 6480464 Losartan results in decreased expression of MAPK14 protein CTD PMID:28091615 losartan multiple interactions EXP 6480464 [Losartan co-treated with Vitamin D] inhibits the reaction [Amiodarone results in increased phosphorylation of MAPK14 protein], Losartan inhibits the reaction [Amiodarone results in increased phosphorylation of MAPK14 protein] CTD PMID:34590760 lycopene decreases expression ISO RGD:619564 6480464 lycopene results in decreased expression of MAPK14 protein CTD PMID:17337101 lycopene multiple interactions EXP 6480464 Lycopene inhibits the reaction [Oxaliplatin results in increased expression of MAPK14 protein] CTD PMID:32544411 lycopene increases expression ISO RGD:619564 6480464 lycopene results in increased expression of MAPK14 mRNA CTD PMID:16886892 lycorine multiple interactions ISO RGD:619565 6480464 lycorine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] CTD PMID:22155741 malvidin multiple interactions ISO RGD:619564 6480464 malvidin results in increased expression of and results in increased phosphorylation of MAPK14 protein CTD PMID:15964118 manganese atom decreases phosphorylation ISO RGD:619564 6480464 Manganese results in decreased phosphorylation of MAPK14 protein CTD PMID:17043766 manganese(0) decreases phosphorylation ISO RGD:619564 6480464 Manganese results in decreased phosphorylation of MAPK14 protein CTD PMID:17043766 manganese(II) chloride increases phosphorylation ISO RGD:619564 6480464 manganese chloride results in increased phosphorylation of MAPK14 protein CTD PMID:15737199 manganese(II) chloride increases expression ISO RGD:619565 6480464 manganese chloride results in increased expression of MAPK14 mRNA CTD PMID:17467022 melamine increases expression ISO RGD:619565 6480464 melamine results in increased expression of MAPK14 mRNA CTD PMID:34842327 mercury dichloride increases phosphorylation ISO RGD:619564 6480464 Mercuric Chloride results in increased phosphorylation of MAPK14 protein CTD PMID:15585369 mesalamine multiple interactions EXP 6480464 Mesalamine inhibits the reaction [Acetic Acid results in increased expression of MAPK14 mRNA] CTD PMID:29518435 metam multiple interactions ISO RGD:619565 6480464 methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] CTD PMID:15933225 metformin multiple interactions ISO RGD:619564 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of MAPK14 mRNA CTD PMID:29309887 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of MAPK14 mRNA CTD PMID:16393664 , PMID:30467583 methidathion decreases expression ISO RGD:619565 6480464 methidathion results in decreased expression of MAPK14 mRNA CTD PMID:34813904 methotrexate increases phosphorylation ISO RGD:619564 6480464 Methotrexate results in increased phosphorylation of MAPK14 protein CTD PMID:19100307 methotrexate multiple interactions ISO RGD:619564 6480464 SB 203580 inhibits the reaction [Methotrexate results in increased phosphorylation of MAPK14 protein] CTD PMID:19100307 methotrexate decreases expression ISO RGD:619564 6480464 Methotrexate results in decreased expression of MAPK14 mRNA CTD PMID:19100307 methylmercury(1+) increases expression ISO RGD:619564 6480464 methylmercury II results in increased expression of MAPK14 mRNA CTD PMID:26314263 microcystin-LR multiple interactions EXP 6480464 cyanoginosin LR results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:22000993 microcystin-LR increases phosphorylation EXP 6480464 cyanoginosin LR results in increased phosphorylation of MAPK14 protein CTD PMID:22000993 mitomycin C multiple interactions ISO RGD:619564 6480464 Dexamethasone inhibits the reaction [Mitomycin results in increased activity of and results in increased phosphorylation of MAPK14 protein], Mitomycin results in increased activity of and results in increased phosphorylation of MAPK14 protein CTD PMID:20002897 morphine increases expression EXP 6480464 Morphine results in increased expression of MAPK14 protein CTD PMID:23056601 N-acetyl-L-cysteine multiple interactions ISO RGD:619564 6480464 Acetylcysteine inhibits the reaction [[4-hydroxy-2-nonenal co-treated with Hydrogen Peroxide] results in increased activity of MAPK14 protein] more ... CTD PMID:12684028 more ... N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK14 protein] CTD PMID:18703135 N-formyl-L-methionyl-L-leucyl-L-phenylalanine multiple interactions ISO RGD:619564 6480464 N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK14 protein, Omeprazole inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK14 protein] CTD PMID:17406807 N-formyl-L-methionyl-L-leucyl-L-phenylalanine increases phosphorylation ISO RGD:619565 6480464 N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK14 protein CTD PMID:16621998 N-methyl-4-phenylpyridinium increases phosphorylation EXP 6480464 1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAPK14 protein CTD PMID:22019741 N-methyl-N'-nitro-N-nitrosoguanidine increases phosphorylation ISO RGD:619564 6480464 Methylnitronitrosoguanidine results in increased phosphorylation of MAPK14 protein CTD PMID:22001597 N-methyl-N-nitrosourea multiple interactions EXP 6480464 Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:12693035 N-Nitroso-N-methylurethane multiple interactions EXP 6480464 Nitrosomethylurethane results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:12693035 N-nitrosodiethylamine multiple interactions ISO RGD:619565 6480464 Butylated Hydroxyanisole inhibits the reaction [MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased activity of MAPK8 protein]] more ... CTD PMID:18691550 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of MAPK14 mRNA more ... CTD PMID:18977376 more ... N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of MAPK14 mRNA CTD PMID:20360939 N-nitrosodiethylamine decreases response to substance ISO RGD:619565 6480464 MAPK14 protein results in decreased susceptibility to Diethylnitrosamine CTD PMID:18691550 nickel atom decreases expression ISO RGD:619564 6480464 Nickel results in decreased expression of MAPK14 mRNA CTD PMID:23195993 nickel atom multiple interactions EXP 6480464 [nickel sulfate results in increased abundance of Nickel] which results in decreased expression of MAPK14 mRNA CTD PMID:31734292 nickel dichloride increases phosphorylation ISO RGD:619564 6480464 nickel chloride results in increased phosphorylation of MAPK14 protein CTD PMID:15737199 nickel sulfate multiple interactions EXP 6480464 [nickel sulfate results in increased abundance of Nickel] which results in decreased expression of MAPK14 mRNA CTD PMID:31734292 nickel sulfate increases phosphorylation ISO RGD:619564 6480464 nickel sulfate results in increased phosphorylation of MAPK14 protein CTD PMID:35499276 ochratoxin A multiple interactions ISO RGD:619564 6480464 MAPK14 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]] more ... CTD PMID:22230261 ochratoxin A increases expression ISO RGD:619564 6480464 ochratoxin A metabolite results in increased expression of MAPK14 mRNA, ochratoxin A results in increased expression of MAPK14 mRNA CTD PMID:26314263 ochratoxin A increases response to substance ISO RGD:619564 6480464 MAPK14 protein results in increased susceptibility to ochratoxin A CTD PMID:22230261 octanoic acid multiple interactions ISO RGD:619565 6480464 [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein], [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form] CTD PMID:14984747 oleanolic acid decreases phosphorylation ISO RGD:619564 6480464 Oleanolic Acid analog results in decreased phosphorylation of MAPK14 protein CTD PMID:26612655 omeprazole multiple interactions ISO RGD:619564 6480464 Omeprazole inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK14 protein] CTD PMID:17406807 oxaliplatin increases expression EXP 6480464 Oxaliplatin results in increased expression of MAPK14 protein CTD PMID:32544411 oxaliplatin multiple interactions EXP 6480464 Lycopene inhibits the reaction [Oxaliplatin results in increased expression of MAPK14 protein] CTD PMID:32544411 ozone decreases expression EXP 6480464 Ozone results in decreased expression of MAPK14 protein CTD PMID:33146391 paclitaxel multiple interactions ISO RGD:619564 6480464 [esculetin co-treated with Paclitaxel] results in decreased expression of MAPK14 protein, [Paclitaxel co-treated with Metformin] results in decreased expression of MAPK14 mRNA CTD PMID:16051289 , PMID:29309887 paclitaxel multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Paclitaxel results in increased expression of MAPK14 mRNA] CTD PMID:35921949 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of MAPK14 mRNA CTD PMID:35921949 paracetamol affects expression ISO RGD:619565 6480464 Acetaminophen affects the expression of MAPK14 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MAPK14 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:619564 6480464 Acetaminophen results in decreased expression of MAPK14 mRNA CTD PMID:21420995 paraquat multiple interactions ISO RGD:619565 6480464 Paraquat promotes the reaction [endotoxin, Escherichia coli results in increased phosphorylation of MAPK14 protein] CTD PMID:16919916 paraquat multiple interactions EXP 6480464 [Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK14 protein CTD PMID:24376630 paraquat increases phosphorylation EXP 6480464 Paraquat results in increased phosphorylation of MAPK14 protein CTD PMID:17324951 , PMID:17997883 paraquat increases phosphorylation ISO RGD:619565 6480464 Paraquat results in increased phosphorylation of MAPK14 protein CTD PMID:16797015 , PMID:16919916 pentachlorophenol increases expression ISO RGD:619565 6480464 Pentachlorophenol results in increased expression of MAPK14 mRNA CTD PMID:23892564 perfluorononanoic acid affects expression EXP 6480464 perfluoro-n-nonanoic acid affects the expression of MAPK14 mRNA CTD PMID:19196829 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:619565 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MAPK14 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:619565 6480464 perfluorooctanoic acid results in increased expression of MAPK14 protein CTD PMID:28126411 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of MAPK14 mRNA CTD PMID:20360939 phenylephrine increases phosphorylation EXP 6480464 Phenylephrine results in increased phosphorylation of MAPK14 protein CTD PMID:15757502 PhIP affects expression ISO RGD:619564 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine affects the expression of MAPK14 mRNA CTD PMID:20702593 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:619564 6480464 SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]] more ... CTD PMID:14610070 , PMID:17309078 phorbol 13-acetate 12-myristate increases activity ISO RGD:619564 6480464 Tetradecanoylphorbol Acetate results in increased activity of MAPK14 protein CTD PMID:12781867 more ... phorbol 13-acetate 12-myristate multiple interactions ISO RGD:619565 6480464 Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK14 protein] CTD PMID:15944151 phorbol 13-acetate 12-myristate increases phosphorylation ISO RGD:619564 6480464 Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK14 protein CTD PMID:16838270 phosalone multiple interactions EXP 6480464 Ellagic Acid inhibits the reaction [phosalone results in increased expression of MAPK14 protein] CTD PMID:27965107 phosalone increases expression EXP 6480464 phosalone results in increased expression of MAPK14 protein CTD PMID:27965107 phytosphingosine multiple interactions ISO RGD:619564 6480464 3 more ... CTD PMID:17237268 picoxystrobin decreases expression ISO RGD:619564 6480464 picoxystrobin results in decreased expression of MAPK14 mRNA CTD PMID:33512557 pirfenidone decreases expression EXP 6480464 pirfenidone results in decreased expression of MAPK14 protein CTD PMID:28091615 potassium chromate multiple interactions ISO RGD:619564 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAPK14 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:619564 6480464 potassium chromate(VI) results in decreased expression of MAPK14 mRNA CTD PMID:22079256 prednisolone multiple interactions EXP 6480464 Prednisolone inhibits the reaction [Amiodarone results in increased phosphorylation of MAPK14 protein] CTD PMID:34590760 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of MAPK14 mRNA CTD PMID:19162173 procyanidin B1 multiple interactions ISO RGD:619564 6480464 procyanidin B1 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] CTD PMID:26037075 progesterone multiple interactions EXP 6480464 Progesterone promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein] CTD PMID:16284289 prostaglandin E2 increases activity ISO RGD:619565 6480464 Dinoprostone results in increased activity of MAPK14 protein CTD PMID:16644903 prostaglandin E2 increases phosphorylation EXP 6480464 Dinoprostone results in increased phosphorylation of MAPK14 protein CTD PMID:18030065 prostaglandin E2 multiple interactions ISO RGD:619565 6480464 L-826266 inhibits the reaction [Dinoprostone results in increased activity of MAPK14 protein] CTD PMID:16644903 protein kinase inhibitor decreases activity ISO RGD:619564 6480464 Protein Kinase Inhibitors results in decreased activity of MAPK14 protein CTD PMID:27807932 protein kinase inhibitor multiple interactions ISO RGD:619564 6480464 [Protein Kinase Inhibitors results in decreased activity of MAPK14 protein] inhibits the reaction [taiwanin E results in decreased expression of MMP2 mRNA] more ... CTD PMID:27807932 pterostilbene multiple interactions ISO RGD:619564 6480464 MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide more ... CTD PMID:19549798 pyrazoles decreases activity ISO RGD:619564 6480464 Pyrazoles analog results in decreased activity of MAPK14 protein CTD PMID:12534346 pyrimidines decreases activity ISO RGD:619564 6480464 Pyrimidines analog results in decreased activity of MAPK14 protein CTD PMID:12534346 quercetin multiple interactions ISO RGD:619565 6480464 MAPK14 protein promotes the reaction [Quercetin promotes the reaction [NR1H3 protein binds to ABCA1 promoter]] more ... CTD PMID:22711909 quercetin increases expression ISO RGD:619564 6480464 Quercetin results in increased expression of MAPK14 protein modified form CTD PMID:22197970 rac-lactic acid decreases expression ISO RGD:619564 6480464 Lactic Acid results in decreased expression of MAPK14 mRNA CTD PMID:30851411 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of MAPK14 mRNA CTD PMID:16079270 razoxane multiple interactions EXP 6480464 Razoxane inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK14 protein] CTD PMID:16213474 reactive oxygen species increases activity ISO RGD:619564 6480464 Reactive Oxygen Species results in increased activity of MAPK14 protein CTD PMID:17237268 reactive oxygen species multiple interactions EXP 6480464 [Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK14 protein CTD PMID:24376630 reactive oxygen species multiple interactions ISO RGD:619565 6480464 MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased abundance of Reactive Oxygen Species] CTD PMID:18691550 resveratrol affects expression EXP 6480464 resveratrol affects the expression of MAPK14 mRNA CTD PMID:15748624 resveratrol multiple interactions ISO RGD:619564 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of MAPK14 mRNA CTD PMID:23557933 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of MAPK14 mRNA] CTD PMID:25833014 resveratrol decreases expression ISO RGD:619564 6480464 resveratrol results in decreased expression of MAPK14 protein CTD PMID:18089832 resveratrol multiple interactions ISO RGD:619565 6480464 [resveratrol co-treated with Glucose] results in decreased expression of MAPK14 mRNA, resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:16322078 , PMID:24659233 retinyl acetate increases expression ISO RGD:619565 6480464 retinol acetate results in increased expression of MAPK14 mRNA CTD PMID:16772331 rotenone multiple interactions ISO RGD:619564 6480464 Rotenone inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein], Rotenone results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:14976342 , PMID:15650392 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MAPK14 protein CTD PMID:28238857 rotenone multiple interactions EXP 6480464 [Levodopa co-treated with Rotenone] results in decreased expression of MAPK14 mRNA, asiaticoside inhibits the reaction [Rotenone results in decreased expression of MAPK14 protein] CTD PMID:28238857 rotenone increases phosphorylation ISO RGD:619564 6480464 Rotenone results in increased phosphorylation of MAPK14 protein CTD PMID:17324951 , PMID:19777565 rottlerin decreases phosphorylation ISO RGD:619564 6480464 rottlerin results in decreased phosphorylation of MAPK14 protein CTD PMID:15949478 rutin multiple interactions ISO RGD:619565 6480464 Rutin inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK14 protein] CTD PMID:35304134 S-butyl-DL-homocysteine (S,R)-sulfoximine increases phosphorylation ISO RGD:619564 6480464 Buthionine Sulfoximine results in increased phosphorylation of MAPK14 protein CTD PMID:17191120 Salinomycin decreases expression ISO RGD:619564 6480464 salinomycin results in decreased expression of MAPK14 mRNA CTD PMID:19682730 salubrinal multiple interactions ISO RGD:619564 6480464 salubrinal inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK14 protein] CTD PMID:21809093 SB 203580 multiple interactions ISO RGD:619564 6480464 MAPK14 protein mutant form inhibits the reaction [SB 203580 inhibits the reaction [arsenite results in increased phosphorylation of EIF4E protein]] more ... CTD PMID:12781867 more ... SB 203580 decreases activity EXP 6480464 SB 203580 results in decreased activity of MAPK14 protein CTD PMID:24376630 SB 203580 decreases activity ISO RGD:619565 6480464 SB 203580 results in decreased activity of MAPK14 protein CTD PMID:15585325 SB 203580 multiple interactions ISO RGD:619565 6480464 [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein] more ... CTD PMID:10704466 more ... SB 203580 decreases activity ISO RGD:619564 6480464 SB 203580 results in decreased activity of MAPK14 protein CTD PMID:10998351 more ... SB 203580 multiple interactions EXP 6480464 [SB 203580 inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in increased phosphorylation of MAPK14 protein more ... CTD PMID:11709198 more ... scullcapflavone II affects binding ISO RGD:619564 6480464 skullcapflavone II binds to MAPK14 protein CTD PMID:32913905 serpentine asbestos increases phosphorylation ISO RGD:619564 6480464 Asbestos, Serpentine results in increased phosphorylation of MAPK14 protein CTD PMID:15882436 silver atom multiple interactions ISO RGD:619564 6480464 NFKBIA protein inhibits the reaction [Silver results in increased phosphorylation of MAPK14 protein] CTD PMID:22342292 silver atom affects expression ISO RGD:619564 6480464 Silver affects the expression of MAPK14 mRNA CTD PMID:22342292 silver atom increases phosphorylation ISO RGD:619564 6480464 Silver results in increased phosphorylation of MAPK14 protein CTD PMID:22342292 silver(0) multiple interactions ISO RGD:619564 6480464 NFKBIA protein inhibits the reaction [Silver results in increased phosphorylation of MAPK14 protein] CTD PMID:22342292 silver(0) affects expression ISO RGD:619564 6480464 Silver affects the expression of MAPK14 mRNA CTD PMID:22342292 silver(0) increases phosphorylation ISO RGD:619564 6480464 Silver results in increased phosphorylation of MAPK14 protein CTD PMID:22342292 simvastatin multiple interactions ISO RGD:619565 6480464 Simvastatin results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:17928392 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of MAPK14 mRNA CTD PMID:16414398 sodium arsenate decreases expression ISO RGD:619565 6480464 sodium arsenate results in decreased expression of MAPK14 mRNA CTD PMID:30953684 sodium arsenite increases expression ISO RGD:619565 6480464 sodium arsenite results in increased expression of MAPK14 mRNA CTD PMID:28370166 , PMID:28757890 sodium arsenite decreases expression ISO RGD:619565 6480464 sodium arsenite results in decreased expression of MAPK14 mRNA CTD PMID:31233874 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of MAPK14 mRNA, sodium arsenite results in increased expression of MAPK14 protein CTD PMID:11446828 , PMID:24497207 sodium arsenite increases activity EXP 6480464 sodium arsenite results in increased activity of MAPK14 protein CTD PMID:8971075 , PMID:9288946 sodium arsenite multiple interactions EXP 6480464 p-coumaric acid inhibits the reaction [sodium arsenite results in increased expression of MAPK14 mRNA] more ... CTD PMID:16818494 more ... sodium arsenite increases phosphorylation ISO RGD:619565 6480464 sodium arsenite results in increased phosphorylation of MAPK14 protein CTD PMID:10704466 sodium arsenite multiple interactions ISO RGD:619565 6480464 Drugs more ... CTD PMID:10704466 , PMID:28757890 sodium arsenite increases phosphorylation ISO RGD:619564 6480464 sodium arsenite results in increased phosphorylation of MAPK14 protein CTD PMID:21642427 sodium arsenite multiple interactions ISO RGD:619564 6480464 sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:15504454 sodium arsenite increases activity ISO RGD:619564 6480464 sodium arsenite results in increased activity of MAPK14 protein CTD PMID:22706169 sodium chloride multiple interactions ISO RGD:619565 6480464 Sodium Chloride results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:15975986 sodium dichromate decreases expression ISO RGD:619565 6480464 sodium bichromate results in decreased expression of MAPK14 mRNA CTD PMID:22155349 sodium dodecyl sulfate increases phosphorylation ISO RGD:619564 6480464 Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK14 protein CTD PMID:15737199 Soman multiple interactions EXP 6480464 [asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman results in increased phosphorylation of MAPK14 protein] CTD PMID:21971501 Soman increases phosphorylation EXP 6480464 Soman results in increased phosphorylation of MAPK14 protein CTD PMID:21971501 sorafenib decreases expression ISO RGD:619564 6480464 sorafenib results in decreased expression of MAPK14 protein modified form CTD PMID:16985072 streptozocin increases phosphorylation ISO RGD:619565 6480464 Streptozocin results in increased phosphorylation of MAPK14 protein CTD PMID:15232685 streptozocin increases phosphorylation EXP 6480464 Streptozocin results in increased phosphorylation of MAPK14 protein CTD PMID:17589825 streptozocin multiple interactions EXP 6480464 Atorvastatin inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK14 protein] CTD PMID:17589825 sucrose multiple interactions ISO RGD:619565 6480464 Sucrose results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:15975986 sunitinib increases expression ISO RGD:619564 6480464 Sunitinib results in increased expression of MAPK14 mRNA CTD PMID:31533062 syringic acid decreases expression ISO RGD:619564 6480464 syringic acid results in decreased expression of MAPK14 mRNA CTD PMID:33759321 tamibarotene affects expression ISO RGD:619564 6480464 tamibarotene affects the expression of MAPK14 mRNA CTD PMID:15498508 tamoxifen increases activity ISO RGD:619564 6480464 Tamoxifen results in increased activity of MAPK14 protein CTD PMID:14645110 tamoxifen multiple interactions ISO RGD:619564 6480464 alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased activity of MAPK14 protein] CTD PMID:14645110 taurodeoxycholic acid increases activity ISO RGD:619564 6480464 Taurodeoxycholic Acid results in increased activity of MAPK14 protein CTD PMID:14762791 telmisartan multiple interactions ISO RGD:619564 6480464 telmisartan inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] CTD PMID:22124178 telmisartan decreases phosphorylation EXP 6480464 telmisartan results in decreased phosphorylation of MAPK14 protein CTD PMID:19292980 tert-butyl hydroperoxide decreases expression ISO RGD:619564 6480464 tert-Butylhydroperoxide results in decreased expression of MAPK14 mRNA CTD PMID:15336504 tert-butyl hydroperoxide increases methylation ISO RGD:619564 6480464 tert-Butylhydroperoxide results in increased methylation of MAPK14 gene CTD PMID:27509014 tert-butyl hydroperoxide increases expression ISO RGD:619564 6480464 tert-Butylhydroperoxide results in increased expression of MAPK14 mRNA CTD PMID:27509014 , PMID:29432895 testosterone decreases expression ISO RGD:619565 6480464 Testosterone results in decreased expression of MAPK14 mRNA CTD PMID:21669218 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MAPK14 protein] CTD PMID:21094144 tetrachloroethene increases expression ISO RGD:619564 6480464 Tetrachloroethylene results in increased expression of MAPK14 mRNA CTD PMID:16010555 tetrachloromethane decreases phosphorylation EXP 6480464 Carbon Tetrachloride results in decreased phosphorylation of MAPK14 protein CTD PMID:17285312 tetrachloromethane multiple interactions EXP 6480464 Carbon Tetrachloride results in increased phosphorylation of and results in increased activity of MAPK14 protein, FR 167653 inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:17334410 tetraphene multiple interactions ISO RGD:619564 6480464 Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased phosphorylation of MAPK14 protein], SB 203580 inhibits the reaction [benz(a)anthracene results in increased phosphorylation of MAPK14 protein] CTD PMID:21635667 tetraphene increases phosphorylation ISO RGD:619564 6480464 benz(a)anthracene results in increased phosphorylation of MAPK14 protein CTD PMID:21635667 thalidomide increases phosphorylation ISO RGD:619564 6480464 Thalidomide analog results in increased phosphorylation of MAPK14 protein CTD PMID:15858615 thimerosal increases phosphorylation ISO RGD:619564 6480464 Thimerosal results in increased phosphorylation of MAPK14 protein CTD PMID:15737199 thimerosal decreases expression ISO RGD:619564 6480464 Thimerosal results in decreased expression of MAPK14 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MAPK14 protein CTD PMID:15953624 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of MAPK14 mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of MAPK14 mRNA CTD PMID:23830814 titanium dioxide multiple interactions ISO RGD:619564 6480464 NFKBIA protein inhibits the reaction [titanium dioxide results in increased phosphorylation of MAPK14 protein] CTD PMID:22342292 titanium dioxide increases expression ISO RGD:619564 6480464 titanium dioxide results in increased expression of MAPK14 mRNA CTD PMID:22342292 titanium dioxide increases phosphorylation ISO RGD:619564 6480464 titanium dioxide results in increased phosphorylation of MAPK14 protein CTD PMID:22342292 trans-chalcone multiple interactions ISO RGD:619565 6480464 Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] CTD PMID:22155221 tributylstannane increases expression ISO RGD:619564 6480464 tributyltin results in increased expression of MAPK14 mRNA CTD PMID:26314263 Tributyltin oxide decreases expression EXP 6480464 bis(tri-n-butyltin)oxide results in decreased expression of MAPK14 mRNA CTD PMID:17553608 Tributyltin oxide increases expression ISO RGD:619564 6480464 bis(tri-n-butyltin)oxide results in increased expression of MAPK14 mRNA CTD PMID:26314263 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of MAPK14 mRNA CTD PMID:19448997 trichostatin A multiple interactions ISO RGD:619564 6480464 DUSP1 mutant form inhibits the reaction [trichostatin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein]], trichostatin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] CTD PMID:21911040 trichostatin A affects expression ISO RGD:619564 6480464 trichostatin A affects the expression of MAPK14 mRNA CTD PMID:28542535 trifluoperazine multiple interactions ISO RGD:619564 6480464 Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:21544200 trifluoperazine multiple interactions ISO RGD:619565 6480464 Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:21544200 trifluoperazine multiple interactions EXP 6480464 Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:21544200 trimethylarsine oxide increases expression EXP 6480464 trimethylarsine oxide results in increased expression of MAPK14 mRNA CTD PMID:17481689 Triptolide multiple interactions ISO RGD:619564 6480464 triptolide inhibits the reaction [Asbestos, Crocidolite results in decreased phosphorylation of MAPK14 protein] CTD PMID:17507666 triptonide increases expression ISO RGD:619565 6480464 triptonide results in increased expression of MAPK14 mRNA CTD PMID:33045310 tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate multiple interactions EXP 6480464 [asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman results in increased phosphorylation of MAPK14 protein] CTD PMID:21971501 tunicamycin decreases expression ISO RGD:619565 6480464 Tunicamycin results in decreased expression of MAPK14 mRNA CTD PMID:17127020 tyrphostin AG 1478 multiple interactions ISO RGD:619564 6480464 RTKI cpd inhibits the reaction [Acrolein results in increased phosphorylation of MAPK14 protein] CTD PMID:11329622 valproic acid affects expression ISO RGD:619564 6480464 Valproic Acid affects the expression of MAPK14 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:619564 6480464 Valproic Acid results in increased expression of MAPK14 protein CTD PMID:29501571 vanadyl sulfate decreases expression ISO RGD:619564 6480464 vanadyl sulfate results in decreased expression of MAPK14 mRNA CTD PMID:16330358 vitamin D multiple interactions EXP 6480464 [Losartan co-treated with Vitamin D] inhibits the reaction [Amiodarone results in increased phosphorylation of MAPK14 protein], Vitamin D inhibits the reaction [Amiodarone results in increased phosphorylation of MAPK14 protein] CTD PMID:34590760 vorinostat multiple interactions ISO RGD:619564 6480464 [Bortezomib co-treated with vorinostat] results in increased phosphorylation of MAPK14 protein CTD PMID:12893773 VX-745 decreases activity ISO RGD:619564 6480464 VX-745 results in decreased activity of MAPK14 protein CTD PMID:28629242 wortmannin multiple interactions ISO RGD:619565 6480464 wortmannin promotes the reaction [Tretinoin results in increased phosphorylation of MAPK14 protein] CTD PMID:12032135 xanthohumol decreases phosphorylation ISO RGD:619564 6480464 xanthohumol results in decreased phosphorylation of MAPK14 protein CTD PMID:35229981 Y-27632 multiple interactions ISO RGD:619564 6480464 Y 27632 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] CTD PMID:22226621
